Quality-of-Life Outcomes Underreported in GU Cancer Trials

(MedPage Today) — SAN FRANCISCO — Despite increasing emphasis on quality of life (QoL) metrics and patient-reported outcomes in cancer trials, reporting of these outcomes has been inconsistent for prostate, kidney, and bladder cancer trials…